Use of gEUD for predicting ear and pituitary gland damage following proton and photon radiation therapy

British Journal of Radiology

Volumn 88, Issue 1048, 2015, Pages

  De Marzi, L ^a   Feuvret, L ^b   Boule, T ^c   Habrand, J L ^d   Martin, F ^a   Calugaru, V ^a   Fournier Bidoz, N ^a   Ferrand, R ^e   Mazal, A ^a  

^a INSTITUT CURIE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c DOSIsoft SA   (France)

^d Centre Henri Baclesse   (France)

^e INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUDIOMETRY; CHILD; CHONDROSARCOMA; CHORDOMA; COCHLEA; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; FOLLOW UP; GENERALIZED EQUIVALENT UNIFORM DOSE; HEARING IMPAIRMENT; HISTOGRAM; HUMAN; HYPOPHYSIS; HYPOPHYSIS DISEASE; HYPOTHALAMUS; INNER EAR; INTERNAL AUDITORY CANAL; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANS AT RISK; OTITIS MEDIA; OUTCOME ASSESSMENT; PHOTON THERAPY; PREDICTIVE VALUE; PROTON RADIATION; PROTON THERAPY; PURE TONE AUDIOMETRY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RADIATION RESPONSE; RADIOTHERAPY PLANNING SYSTEM; RETROSPECTIVE STUDY; SKULL BASE TUMOR; TINNITUS; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HEARING LOSS; MALE; PHOTON; RADIATION INJURIES; SKULL BASE NEOPLASMS;

PROTON;

ADULT; AUDIOMETRY; CHILD; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEARING LOSS; HUMANS; HYPOTHALAMUS; MALE; ORGANS AT RISK; PHOTONS; PITUITARY GLAND; PREDICTIVE VALUE OF TESTS; PROTONS; RADIATION DOSAGE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SKULL BASE NEOPLASMS;

EID: 84930346583     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20140413     Document Type: Article

References (34)

1. Noël G, Feuvret L, Calugaru V, Dhermain F, Mammar H, Haie-Méder C, et al. Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncol 2005; 44: 700-8.
2. Schot LJ, Hilgers FJ, Keus RB, Schouwenburg PF, Dreschler WA. Late effects of radiotherapy on hearing. Eur Arch Otorhinolaryngol 1992; 249: 305-8.
3. Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR. Prospective study of inner ear radiation dose and hearing loss in head-And-neck cancer patients. Int J Radiat Oncol Biol Phys 2005; 61: 1393-402.
4. Bakhshandeh M, Hashemi B, Mahdavi SR, Nikoofar A, Vasheghani M, Kazemnejad A. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-And-neck radiation therapy. Int J Radiat Oncol Biol Phys 2013; 85: 514-21. doi: 10.1016/j.ijrobp.2012.03.034
5. Bhandare N, Kennedy L, Malyapa RS, Morris CG, Mendenhall WM. Primary and central hypothyroidism after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys 2007; 68: 1131-9.
6. Pai HH, Thornton A, Katznelson L, Finkelstein DM, Adams JA, Fullerton BC, et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2001; 49: 1079-92.
7. Calugaru V, Nauraye C, Noël G, Giocanti N, Favaudon V, Mégnin-Chanet F. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay. Int J Radiat Oncol Biol Phys 2011; 81: 1136-43. doi: 10.1016/j. ijrobp.2010.09.003
8. Feuvret L, Noel G, Weber DC, Pommier P, Ferrand R, De Marzi L, et al. A treatment planning comparison of combined photonproton beams versus proton beams-only for the treatment of skull base tumors. Int J Radiat Oncol Biol Phys 2007; 69: 944-54.
9. Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R. Optimization of intensitymodulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 2002; 52: 224-35.
10. Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys 1997; 24: 103-10.
11. Niemierko A, Goitein M. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. Radiother Oncol 1991; 20: 166-76.
12. Niemierko A. A generalized concept of equivalent uniform dose, 41th AAPM annual meeting, Nashville, 24-29 July. Med Phys 1999; 26: 1100.
13. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21: 109-22.
14. Bhandare N, Jackson A, Eisbruch A, Pan CC, Flickinger JC, Antonelli P, et al. Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys 2010; 76: S50-7. doi: 10.1016/j. ijrobp.2009.04.096
15. Schultheiss TE, Orton CG, Peck RA. Models in radiotherapy: volume effects Med Phys 1983; 10: 410-15.
16. Boulé TP, Gallardo Fuentes MI, Rosello JV, Arrans Lara R, Torrecilla JL, Plaza AL. Clinical comparative study of dose-volume and equivalent uniform dose based predictions in post radiotherapy acute complications. Acta Oncol 2009; 48: 1044-53. doi: 10.1080/02841860903078513
17. Das SK, Baydush AH, Zhou S, Miften M, Yu X, Craciunescu O, et al. Predicting radiotherapy-induced cardiac perfusion defects. Med Phys 2005; 32: 19-27.
18. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
19. Allen Li X, Alber M, Deasy JO, Jackson A, Ken Jee KW, Marks LB, et al. The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys 2012; 39: 1386-409.
20. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991; 21: 123-35.
21. Bentzen SM, Tucker SL. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol 1997; 71: 531-42.
22. Gottschalk B, Koehler AM, Schneider RJ, Sisterson JM, Wagner MS. Multiple Coulomb scattering of 160 MeV protons. Nucl Instrum Methods Phys Res B 1993; 74: 467-90.
23. Hong L, Goitein M, Bucciolini M, Comiskey R, Gottschalk B, Rosenthal S, et al. A pencil beam algorithm for proton dose calculations. Phys Med Biol 1996; 41: 1305-30.
24. Szymanowski H, Mazal A, Nauraye C, Biensan S, Ferrand R, Murillo MC, et al. Experimental determination and verification of the parameters used in a proton pencil beam algorithm. Med Phys 2001; 28: 975-87.
25. Kappas K, Rosenwald JC. A 3D beam subtraction method for inhomogeneity correction in high energy X-ray radiotherapy. Radiother Oncol 1986; 5: 223-33.
26. Abramowitz M, Stegun IA. Handbook of mathematical functions with formulas, graphs, and mathematical tables. 9th edn. New York, NY: Dover; 1972.
27. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control 1974; 19: 716-23.
28. Honoré HB, Bentzen SM, Mller K, Grau C. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation. Radiother Oncol 2002; 65: 9-16.
29. Gay HA, Niemierko A. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. Phys Med 2007; 23: 115-25.
30. Darzy KH. Radiation-induced hypopituitarism after cancer therapy: who, how and when to test. Nat Clin Pract Endocrinol Metab 2009; 5: 88-99. doi: 10.1038/ncpendmet1051
31. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010; 76(Suppl. 3): S10-19. doi: 10.1016/j.ijrobp.2009.07.1754
32. Park CS, Kim Y, Lee N, Bucci KM, Quivey JM, Verhey LJ, et al. Method to account for dose fractionation in analysis of IMRT plans: modified equivalent uniform dose. Int J Radiat Oncol Biol Phys 2005; 62: 925-32.
33. Zaider M, Amols HI. Practical considerations in using calculated healthy-Tissue complication probabilities for treatment-plan optimization. Int J Radiat Oncol Biol Phys 1999; 44: 439-47.
34. Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol 2014; 59: R419-72. doi: 10.1088/0031-9155/59/22/R419